Atazanavir and Crixivan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atazanavir (atazanavir) and Crixivan (indinavir sulfate). Common drug interactions include hepatic enzyme increased among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Atazanavir and Crixivan. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Atazanavir?

Atazanavir has active ingredients of atazanavir. eHealthMe is studying from 2,296 Atazanavir users. Check the latest studies of Atazanavir.

What is Crixivan?

Crixivan has active ingredients of indinavir sulfate. eHealthMe is studying from 6,312 Crixivan users. Check the latest studies of Crixivan.



On Jul, 12, 2026

23 people who take Atazanavir and Crixivan together, and have interactions are studied.

Atazanavir and Crixivan drug interactions.

What are the common drug interactions of Atazanavir and Crixivan, by gender? *:

female:

  1. Hepatic enzyme increased
  2. Premature labour
  3. Maternal exposure during pregnancy (use of substance during pregnancy)

male:

  1. Emotional distress
  2. Pain
  3. Osteonecrosis (death of bone)
  4. Back pain
  5. Decreased activity
  6. Post-traumatic stress disorder
  7. Renal failure (kidney dysfunction)
  8. Renal impairment (severely reduced kidney function)
  9. Spinal compression fracture (fracture due to spinal compression on bone)
  10. Abdominal pain upper

What are the common drug interactions of Atazanavir and Crixivan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dizziness
  2. Fibrin degradation products increased
  3. Influenza like illness
  4. Nausea (feeling of having an urge to vomit)
  5. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  6. Palpitations (feelings or sensations that your heart is pounding or racing)
  7. Pulmonary hypertension (increase in blood pressure in the lung artery)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Visual impairment

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Blood creatinine increased
  4. Bone density decreased
  5. Bone loss
  6. Chronic kidney disease
  7. Depression
  8. Emotional distress
  9. Nephropathy (damage to or disease of a kidney)
  10. Osteonecrosis (death of bone)

50-59:

  1. Abdominal pain upper
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Cachexia (loss of weight)
  5. Diarrhoea
  6. Emotional distress
  7. Femur fracture
  8. Flatulence (flatus expelled through the anus)
  9. Joint injury
  10. Limb injury

60+:

  1. Bone density decreased
  2. Emotional distress
  3. Osteonecrosis (death of bone)
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Osteoporosis (bones weak and more likely to break)
  6. Post-traumatic stress disorder
  7. Renal impairment (severely reduced kidney function)
  8. Spinal compression fracture (fracture due to spinal compression on bone)
  9. Renal failure (kidney dysfunction)
  10. Gait disturbance

What are the existing conditions these people have? *

  1. Hiv Infection: 21 people, 91.30%
  2. High Blood Pressure: 7 people, 30.43%
  3. Hypersensitivity: 6 people, 26.09%
  4. Pain: 6 people, 26.09%
  5. Bacterial Infection: 3 people, 13.04%
  6. Bone Density Abnormal: 3 people, 13.04%
  7. Cardiac Disorder: 3 people, 13.04%
  8. Cough: 3 people, 13.04%
  9. Depression: 3 people, 13.04%
  10. Diabetes: 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Atazanavir and Crixivan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atazanavir and Crixivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atazanavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Crixivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atazanavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Crixivan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on atazanavir and indinavir sulfate (the active ingredients of Atazanavir and Crixivan, respectively), and Atazanavir and Crixivan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: